{
  "trial_id": "NCT01279304",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "cT1-2 invasive breast cancer",
      "label": "met",
      "evidence": "cytologically confirmed"
    },
    {
      "criterion": "positive axillary lymph nodes",
      "label": "met",
      "evidence": "5 positive lymph nodes"
    },
    {
      "criterion": "At least 3 cycles of primary systemic treatment have been given",
      "label": "met",
      "evidence": "given (irrespective of the regimen)"
    },
    {
      "criterion": "No standard axillary lymph node dissection is performed prior to chemotherapy",
      "label": "met",
      "evidence": "not performed"
    }
  ],
  "exclusion": [
    {
      "criterion": "cT3-T4 invasive breast cancer prior to any treatment",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Patients with > 3 suspicious axillary nodes on imaging",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "cN2-3 prior to any treatment",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "More than focally irradical surgery and breast conserving therapy",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT01279304",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}